WeLeader Biomedical Co

WeLeader Biomedical Co ROA

The Return on Assets (ROA) of WeLeader Biomedical Co (7713.TWO) as of Oct 20, 2026 is 8.52 %. In the previous year, Return on Assets (ROA) was 8.52 % — a change of -0.03% (lower).

ROA

8.52 %

YoY

-0.03%

Last updated:

In 2025, WeLeader Biomedical Co's return on assets (ROA) was 8.52 %, a -0.03% increase from the 8.52 % ROA in the previous year.

The WeLeader Biomedical Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2020
5.55 TWD
Jan 1, 2021
11.98 TWD
Jan 1, 2022
9.61 TWD
Jan 1, 2023
8.81 TWD
Jan 1, 2024
8.52 TWD
Jan 1, 2025
8.52 TWD
The WeLeader Biomedical Co ROA history
YEARROAYoY
8.52 %-0.03%
8.52 %-3.36%
8.81 %-8.27%
9.61 %-19.77%
11.98 %+115.74%
5.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co Ltd generates revenue through the agency and trading of in vitro diagnostic instruments and reagent-related products, primarily serving domestic markets. The company provides distribution, after-sales, and maintenance services for laboratory reagents, consumables, instruments, and equipment, alongside construction planning for medical testing laboratories. Additional services include equipment procurement, operational coaching, human resources training, and digital medical examination platforms. Domestic clients purchase these integrated solutions for healthcare facilities and laboratories. The firm's product portfolio focuses on medical testing-related services, including operational coaching and digital platform solutions, which are sold to healthcare institutions requiring comprehensive laboratory support. Distribution of in vitro diagnostic instruments and reagents forms a core revenue stream, supported by ancillary services like equipment procurement and site construction planning. These offerings target domestic healthcare providers seeking efficient laboratory management solutions. WeLeader Biomedical Co Ltd's business model combines product sales with service delivery, emphasizing domestic market penetration. The company's revenue is derived from both the sale of diagnostic instruments and reagents and the provision of specialized services such as operational coaching and digital platform access. Healthcare institutions and laboratories are the primary buyers of these integrated offerings, leveraging the company's expertise in laboratory construction and equipment maintenance. WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding WeLeader Biomedical Co's Return on Assets (ROA)

WeLeader Biomedical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing WeLeader Biomedical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider WeLeader Biomedical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in WeLeader Biomedical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about WeLeader Biomedical Co stock

Return on Assets (ROA) of WeLeader Biomedical Co is 8.52 % in 2025.

Return on Assets (ROA) of WeLeader Biomedical Co changed from 8.52 % to 8.52 %, representing a -0.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s WeLeader Biomedical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — WeLeader Biomedical Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — WeLeader Biomedical Co